Today: 21 June 2026

Via Transportation stock tumbles 10% in late trade as Goldman upgrade meets a weak tape

Via Transportation stock tumbles 10% in late trade as Goldman upgrade meets a weak tape

Via Transportation shares fell 10.2% to $24.14 Wednesday, reversing earlier gains despite Goldman Sachs upgrading the stock to Buy and cutting its price target to $44. The company will report fourth-quarter results on Feb. 27. Via’s stock has been volatile since its September IPO at $46. Over 90% of its revenue comes from government contracts, and it posted a net loss in the first half of 2025.
14 January 2026
·
AMD stock keeps KeyBanc upgrade in play as AI server chip supply tightens

AMD stock keeps KeyBanc upgrade in play as AI server chip supply tightens

AMD shares rose 0.6% to $222.27 Wednesday after KeyBanc upgraded the stock to “Overweight,” citing supply-chain checks showing server CPUs are nearly sold out for 2026. Analyst John Vinh raised the price target to $270 and flagged possible 10-15% price hikes in Q1. Investors await AMD’s Feb. 3 earnings for details on AI and data-center demand.
14 January 2026
····
Nebius (NBIS) stock slides 3% as tech weakens; investors eye next AI-cloud catalysts

Nebius (NBIS) stock slides 3% as tech weakens; investors eye next AI-cloud catalysts

Nebius Group N.V. shares fell 3.3% to $101.95 Wednesday afternoon, extending a volatile week for the AI infrastructure firm. Investors are watching a Jan. 29 product webinar and a February delivery milestone tied to a $2.9 billion Meta contract. The stock has swung sharply, jumping 9.6% Monday and falling 1.8% Tuesday. Tech stocks broadly declined, with Nvidia down 2.2% and the Nasdaq-100 ETF off 1.4%.
14 January 2026
···
Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

Lockheed Martin shares rose 2.3% to $571.40 Wednesday after the company announced its first flight test of the Next-Generation Short-Range Interceptor at White Sands. The gains outpaced the S&P 500, which fell 0.8%. Investors responded to new Pentagon efforts to secure the missile supply chain, including a $1 billion investment in L3Harris Technologies’ rocket-motor division.
14 January 2026
····
RTX stock rises as Airbus flags “very, very late” Pratt & Whitney engine deliveries

RTX stock rises as Airbus flags “very, very late” Pratt & Whitney engine deliveries

RTX shares rose 1.6% to $197.29 Wednesday, outperforming a weaker U.S. market after Airbus warned that Pratt & Whitney engine deliveries remain “very, very late.” Airbus said it has not reached a supply agreement with RTX for future engines. Investors are watching RTX’s Jan. 27 earnings for 2026 guidance and updates on engine production.
14 January 2026
······
Trip.com stock sinks nearly 18% after China antitrust probe notice — what investors watch now

Trip.com stock sinks nearly 18% after China antitrust probe notice — what investors watch now

Trip.com’s U.S.-listed shares plunged 17.7% to $62.26 after China’s market regulator opened an antitrust investigation into the company. The State Administration for Market Regulation is probing suspected abuse of market dominance but has not detailed the allegations. Trip.com said operations continue as normal and pledged cooperation. Hong Kong shares fell 6.5% earlier in the day.
14 January 2026
···
Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

Shares of Praxis Precision Medicines rose about 8% to $303.23 by mid-afternoon Wednesday after the company named epilepsy specialist Dr. Orrin Devinsky as head of clinical strategy. Investors are watching two FDA drug applications set for mid-February. Praxis recently raised $575 million in a public offering. The broader biotech sector outperformed the market, while major indexes fell.
14 January 2026
·
Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer shares rose 2% to $25.65 Wednesday after CEO Albert Bourla said the company is “all in on obesity” and plans 10 Phase 3 trials for its Metsera compounds by 2026. Pfizer does not expect revenue growth to return until 2029 as it faces patent expirations and weaker COVID-related sales. AbbVie also announced new obesity drug plans. Novo Nordisk warned of tougher competition in 2026.
14 January 2026
···
1 … 850 851 852 853 854 … 2,088

Stock Market Today

  • Israeli Drone Weapons Maker UVision Plans $4 Billion Nasdaq IPO
    June 21, 2026, 4:41 AM EDT. Israeli defense firm UVision Air, controlled by Aaron Frankel, targets a $3.5 billion to $4 billion valuation in its planned Nasdaq initial public offering (IPO) set for July or August. The company, specializing in loitering munitions-suicide drones that locate and strike targets-aims to raise $500 million to $1 billion. After failing to secure pre-IPO institutional backing at a $2.9 billion valuation, Frankel decided to proceed directly with the IPO. JPMorgan leads the offering amid a recent downturn in defense stocks linked to easing U.S.-Iran tensions. UVision's IPO proceeds will partly repay shareholder loans, including loans from Frankel. Institutional investor meetings will begin in mid-July following prospectus publication, with the challenge of attracting investors at a higher valuation than earlier pre-IPO talks.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 21.06.2026

21 June 2026
LIVEMarkets rolling coverageStarted: June 21, 2026, 4:00 AM EDTUpdated: June 21, 2026, 5:05 AM EDT Israeli Drone Weapons Maker UVision Plans $4 Billion Nasdaq IPO June 21, 2026, 4:41 AM EDT. Israeli defense firm UVision Air, controlled by Aaron Frankel, targets a $3.5 billion to $4 billion valuation in its planned Nasdaq initial public offering (IPO) set for July or August. The company, specializing in loitering munitions-suicide drones that locate and strike targets-aims to raise $500 million to $1 billion. After failing to secure pre-IPO institutional backing at a $2.9 billion valuation, Frankel decided to proceed directly with the IPO.
Go toTop